Détail - canceropole-wordpress

Correlation between imaging features and rEm18 antibodies in alveolar echinococcosis: results from a multicenter study in France.

Simon G, Grenouillet F, Richou C, Delabrousse E, Blagoskonov O, Minello A, Thiefin G, Frentiu E, Wallon M, ,Bresson-Hadni S, Calame P

Parasite. 2025 02 7;32:8

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

Degasperi E, Anolli MP, Jachs M, Reiberger T, De Ledinghen V, Metivier S, D'Offizi G, di Maria F, Schramm C, Schmidt H, Zöllner C, Tacke F, Dietz-Fricke C, Wedemeyer H, Papatheodoridi M, Papatheodoridis G, Carey I, Agarwal K, Van Bömmel F, Brunetto MR, Cardoso M, Verucchi G, Ciancio A, Zoulim F, Aleman S, Semmo N, Mangia A, Hilleret MN, Merle U, Santantonio TA, Coppola N, Pellicelli A, Roche B, Causse X, D'Alteroche L, Dumortier J, Ganne N, Heluwaert F, Ollivier I, Roulot D, Viganò M, Loglio A, Federico A, Pileri F, Maracci M, Tonnini M, Arpurt JP, Barange K, Billaud E, Pol S, Gervais A, Minello A, Rosa I, Puoti M, Lampertico P

J Hepatol. 2025 01 8;:

Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide.

El Messaoudi S, Brichler S, Fougerou-Leurent C, Gordien E, Gerber A, Kortebi A, Lagadic G, Subic-Levrero M, Metivier S, Pol S, Minello A, Ratziu V, Leroy V, Mathurin P, Alric L, Coulibaly F, Pawlotsky JM, Zoulim F, de Lédinghen V, Guedj J,

JHEP Rep. 2024 08;6(8):101070

Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.

de Lédinghen V, Fougerou-Leurent C, Le Pabic E, Pol S, Alfaiate D, Lacombe K, Hilleret MN, Lascoux-Combe C, Minello A, Billaud E, Rosa I, Gervais A, Ratziu V, Ganne N, Pageaux GP, Leroy V, Loustaud-Ratti V, Mathurin P, Chas J, Jezequel C, Métivier S, Dumortier J, Arpurt JP, Asselah T, Roche B, Le Gruyer A, Valantin MA, Scholtès C, Gordien E, Tual C, Kortebi A, Coulibaly F, Rosenthal E, Subic-Levrero M, Roulot D, Zoulim F,

JHEP Rep. 2024 08;6(8):101057

French guidelines on TIPS: Indications and modalities.

Larrue H, Allaire M, Weil-Verhoeven D, Barge S, Thabut D, Payance A, Moga L, Jézéquel C, Artru F, Archambeaud I, Elkrief L, Oberti F, Roux C, Laleman W, Rudler M, Dharancy S, Laborde N, Minello A, Mouillot T, Desjonquères E, Wandji LCN, Bourlière M, Ganne-Carrié N, Bureau C,

Liver Int. 2024 05 17;:

Recipient age influences survival after liver transplant: Results of the French national cohort 2007-2017.

Lerosey L, Ksiasek E, Abrahamowicz M, Antoine C, Dharancy S, Dumortier J, Doussot A, Di Martino V, Houssel-Debry P, Conti F, Francoz C, Pageaux GP, Salame E, Faitot F, Coilly A, Hardwigsen J, Decaens T, Chermak F, Muscari F, Anty R, Duvoux C, Abergel A, Minello A, Mouillot T, Binquet C, Latournerie M

Liver Int. 2024 03 7;:

Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits".

Chouik Y, Corpechot C, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Chazouillères O, Conti F, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J

Liver Transpl. 2023 10 4;:

Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical Trial.

Louvet A, Labreuche J, Dao T, Thévenot T, Oberti F, Bureau C, Paupard T, Nguyen-Khac E, Minello A, Bernard-Chabert B, Anty R, Wartel F, Carbonell N, Pageaux GP, Hilleret MN, Moirand R, Nahon P, Potey C, Duhamel A, Mathurin P

JAMA. 2023 05 9;329(18):1558-1566

Long-term outcome of liver transplantation for autoimmune hepatitis: a French nationwide study over 30 years.

Chouik Y, Chazouillères O, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Conti F, Corpechot C, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Maucort-Boulch D, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Serée O, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J

Liver Int. 2023 02 24;:

Liver transplantation for autoimmune hepatitis: pre-transplant does not predict early post-transplant outcome.

Chouik Y, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Chazouillères O, Conti F, Corpechot C, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J

Liver Int. 2022 12 28;:

Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis.

Plessier A, Goria O, Cervoni JP, Ollivier I, Bureau C, Poujol-Robert A, Minello A, Houssel-Debry P, Rautou PE, Payancé A, Scoazec G, Bruno O, Corbic M, Durand F, Vilgrain V, Paradis V, Boudaoud L, de Raucourt E, Roy C, Gault N, Valla D

NEJM Evid. 2022 12;1(12):EVIDoa2200104

Liver Transplantation Using Allografts With Recent Liver Blunt Trauma: A Nationwide Audit From the French CRISTAL Biomedicine Agency Registry.

Seckler F, Turco C, Mohkam K, Addeo P, Robin F, Cauchy F, Maulat C, Brustia R, Paquette B, Faitot F, Weil Verhoeven D, Minello A, Lakkis Z, Di Martino V, Latournerie M, Chiche L, El Amrani M, Bucur P, Navarro F, Chopinet S, Chirica M, Gagnière J, Iannelli A, Cheisson G, Chardot C, Sommacale D, Muscari F, Dondero F, Sulpice L, Bachellier P, Scatton O, Mabrut JY, Heyd B, Doussot A

Transplantation. 2022 11 22;:

Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation.

Georges P, Clerc C, Turco C, Di Martino V, Paquette B, Minello A, Calame P, Magnin J, Vuitton L, Weil-Verhoeven D, Lakkis Z, Vanlemmens C, Latournerie M, Heyd B, Doussot A

Transpl Int. 2022 06 2;35:10292

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.

Pageaux GP, Nzinga CL, Ganne N, Samuel D, Dorival C, Zoulim F, Cagnot C, Decaens T, Thabut D, Asselah T, Mathurin P, Habersetzer F, Bronowicki JP, Guyader D, Rosa I, Leroy V, Chazouilleres O, de Ledinghen V, Bourliere M, Causse X, Cales P, Metivier S, Loustaud-Ratti V, Riachi G, Alric L, Gelu-Simeon M, Minello A, Gournay J, Geist C, Tran A, Abergel A, Portal I, d'Alteroche L, Raffi F, Fontaine H, Carrat F, Pol S,

BMC Infect Dis. 2022 Jan 27;22(1):94

Management of diabetes mellitus in patients with cirrhosis: an overview and joint statement.

Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM,

Diabetes Metab. 2021 Aug 4;:101272

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study.

Lam L, Fontaine H, Bourliere M, Lusivika-Nzinga C, Dorival C, Thabut D, Zoulim F, Habersetzer F, Asselah T, Duclos-Vallee JC, Bronowicki JP, Mathurin P, Decaens T, Ganne N, Guyader D, Leroy V, Rosa I, Ledinghen V, Cales P, Causse X, Larrey D, Chazouilleres O, Gelu-Simeon M, Loustaud-Ratti V, Metivier S, Alric L, Riachi G, Gournay J, Minello A, Tran A, Geist C, Abergel A, Raffi F, D'alteroche L, Portal I, Lapidus N, Pol S, Carrat F,

Clin Res Hepatol Gastroenterol. 2021 Apr 27;:101713

Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.

Mouillot T, Rizk M, Pais de Barros JP, Gilloteau A, Busson A, Bernard-Chabert B, Thiefin G, Barraud H, Bronowicki JP, Richou C, Di Martino V, Doffoel M, Minello A, Latournerie M, Jouve JL, Brondel L, Brindisi MC, Petit JM, Hillon P, Cottet V,

Aliment. Pharmacol. Ther.. 2020 Aug 11;:

Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.

Ben Merabet Y, Barbe C, Heurgue-Berlot A, Thévenot T, Minello A, Habersetzer F, Samuel D, Bernard-Chabert B, Weil-Verhoeven D, Renard P, Clot H, Di Martino V, Louvet H, Bresson-Hadni S, Thiéfin G

Dig. Dis. Sci.. 2020 Jun 30;:

Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.

Kamar N, Abravanel F, Behrendt P, Hofmann J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J,

Clin. Infect. Dis.. 2019 Dec 3;:

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D'Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S,

Lancet. 2019 Feb 11;:

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, Abergel A, Debette-Gratien M, Larrey D, Roux O, Bronowicki JP, Boursier J, de Ledinghen V, Heurgue-Berlot A, Nguyen-Khac E, Zoulim F, Ollivier-Hourmand I, Zarski JP, Nkontchou G, Lemoinne S, Humbert L, Rainteau D, Lefèvre G, de Chaisemartin L, Chollet-Martin S, Gaouar F, Admane FH, Simon T, Poupon R

N. Engl. J. Med.. 2018 06 7;378(23):2171-2181

Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.

Alric L, Ollivier-Hourmand I, Bérard E, Hillaire S, Guillaume M, Vallet-Pichard A, Bernard-Chabert B, Loustaud-Ratti V, Bourlière M, de Ledinghen V, Fouchard-Hubert I, Canva V, Minello A, Nguyen-Khac E, Leroy V, Saadoun D, Trias D, Pol S, Kamar N

Kidney Int.. 2018 May 5;:

The epidemiology of Budd-Chiari syndrome in France.

Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O, Dumortier J, Cervoni JP, Dharancy S, Ganne-Carrié N, Bureau C, Carbonell N, Abergel A, Nousbaum JB, Anty R, Barraud H, Ripault MP, De Ledinghen V, Minello A, Oberti F, Radenne S, Bendersky N, Farges O, Archambeaud I, Guillygomarc'h A, Ecochard M, Ozenne V, Hilleret MN, Nguyen-Khac E, Dauvois B, Perarnau JM, Lefilliatre P, Raabe JJ, Doffoel M, Becquart JP, Saillard E, Valla D, Dao T, Plessier A,

Dig Liver Dis. 2018 Apr 12;:

Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation.

Moulin B, Chevallier O, Abdulmalak G, Luu M, Latournerie M, Minello A, Gehin S, Cercueil JP, Midulla M, Loffroy R

Quant Imaging Med Surg. 2018 Mar;8(2):174-181

Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial.

Guiu B, Jouve JL, Schmitt A, Minello A, Bonnetain F, Cassinotto C, Piron L, Cercueil JP, Loffroy R, Latournerie M, Wendremaire M, Lepage C, Boulin M

J. Hepatol.. 2018 Feb 8;:

Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.

Laurent L, Lemaitre C, Minello A, Plessier A, Lamblin G, Poujol-Robert A, Gervais-Hasenknopf A, Pariente EA, Belenotti P, Mostefa-Kara N, Sogni P, Legrand M, Cournac JM, Tamion F, Savoye G, Bedossa P, Valla DC, Vilgrain V, Goria O

Aliment. Pharmacol. Ther.. 2017 Dec;46(11-12):1070-1076

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.

Oussalah A, Avogbe PH, Guyot E, Chery C, Guéant-Rodriguez RM, Ganne-Carrié N, Cobat A, Moradpour D, Nalpas B, Negro F, Poynard T, Pol S, Bochud PY, Abel L, Jeulin H, Schvoerer E, Chabi N, Amouzou E, Sanni A, Barraud H, Rouyer P, Josse T, Goffinet L, Jouve JL, Minello A, Bonithon-Kopp C, Thiefin G, Di Martino V, Doffoël M, Richou C, Raab JJ, Hillon P, Bronowicki JP, Guéant JL,

Oncotarget. 2017 Sep;8(38):62842-62857

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.

Pol S, Bourliere M, Lucier S, Hezode C, Dorival C, Larrey D, Bronowicki JP, Ledinghen VD, Zoulim F, Tran A, Metivier S, Zarski JP, Samuel D, Guyader D, Marcellin P, Minello A, Alric L, Thabut D, Chazouilleres O, Riachi G, Bourcier V, Mathurin P, Loustaud-Ratti V, D'Alteroche L, Fouchard-Hubert I, Habersetzer F, Causse X, Geist C, Rosa I, Gournay J, Saillard E, Billaud E, Petrov-Sanchez V, Diallo A, Fontaine H, Carrat F,

J. Hepatol.. 2017 Jan;66(1):39-47

Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure.

Dumortier J, Bailly F, Pageaux GP, Vallet-Pichard A, Radenne S, Habersetzer F, Gagnieu MC, Grangé JD, Minello A, Guillaud O, Kamar N, Alric L, Leroy V

Nephrol. Dial. Transplant.. 2016 Oct;:

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.

Oussalah A, Avogbe PH, Guyot E, Chery C, Guéant-Rodriguez RM, Ganne-Carrié N, Cobat A, Moradpour D, Nalpas B, Negro F, Poynard T, Pol S, Bochud PY, Abel L, Jeulin H, Schvoerer E, Chabi N, Amouzou E, Sanni A, Barraud H, Rouyer P, Josse T, Goffinet L, Jouve JL, Minello A, Bonithon-Kopp C, Thiefin G, Di Martino V, Doffoël M, Richou C, Raab JJ, Hillon P, Bronowicki JP, Guéant JL, Study Group FT

Oncotarget. 2016 Aug;:

An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma.

Anota A, Boulin M, Dabakuyo-Yonli S, Hillon P, Cercueil JP, Minello A, Jouve JL, Paoletti X, Bedenne L, Guiu B, Bonnetain F

BMJ Open. 2016 Jun;6(6):e010696

Compound heterozygous PKHD1 variants cause a wide spectrum of ductal plate malformations.

Courcet JB, Minello A, Prieur F, Morisse L, Phelip JM, Beurdeley A, Meynard D, Massenet D, Lacassin F, Duffourd Y, Gigot N, St-Onge J, Hillon P, Vanlemmens C, Mousson C, Cerceuil JP, Guiu B, Thevenon J, Thauvin-Robinet C, Jacquemin E, Riviere JB, Michel-Calemard L, Faivre L

Am J Med Genet A. 2015 Sep 8

Causes of death in people with chronic HBV infection: A population-based cohort study.

Montuclard C, Hamza S, Rollot F, Evrard P, Faivre J, Hillon P, Di Martino V, Minello A

J. Hepatol.. 2015 Jun;62(6):1265-71

Detection of the CALR mutation in the diagnosis of splanchnic vein thrombosis.

Roques M, Park JH, Minello A, Bastie JN, Girodon F

Br J Haematol. 2015 May;169(4):601-3

Effect of Albumin in Cirrhotic Patients with Infection Other Than Spontaneous Bacterial Peritonitis. A Randomized Trial.

Thevenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, Rudler M, Heurgue-Berlot A, Rosa I, Talbodec N, Dao T, Ozenne V, Carbonell N, Causse X, Goria O, Minello A, De Ledinghen V, Amathieu R, Barraud H, Nguyen-Khac E, Becker C, Paupard T, Botta-Fridlung D, Abdelli N, Guillemot F, Monnet E, Di Martino V

J Hepatol. 2014 Nov 21. pii: S0168-8278(14)00862-9

Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.

Boulin M, Hillon P, Cercueil JP, Bonnetain F, Dabakuyo S, Minello A, Jouve JL, Lepage C, Bardou M, Wendremaire M, Guerard P, Denys A, Grandvuillemin A, Chauffert B, Bedenne L, Guiu B

Aliment Pharmacol Ther. 2014 Jun;39(11):1301-13

Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.

Perarnau JM, Le Gouge A, Nicolas C, d'Alteroche L, Borentain P, Saliba F, Minello A, Anty R, Chagneau-Derrode C, Bernard PH, Abergel A, Ollivier-Hourmand I, Gournay J, Ayoub J, Gaborit C, Rusch E, Giraudeau B

J Hepatol. 2014 May;60(5):962-8

Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.

Boulin M, Adam H, Guiu B, Aho LS, Cercueil JP, Di Martino C, Fagnoni P, Minello A, Jouve JL, Hillon P, Bedenne L, Lepage C

Dig Liver Dis. 2014 Apr;46(4):358-62

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D'Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V

N Engl J Med. 2014 Mar 20;370(12):1111-20

Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study.

Piroth L, Pechinot A, Di Martino V, Hansmann Y, Putot A, Patry I, Hadou T, Jaulhac B, Chirouze C, Rabaud C, Lozniewski A, Neuwirth C, Chavanet P, Minello A

BMC Infect Dis. 2014 May 23;14:287

[Improving compliance with hepatitis c].

Enel C, Minello A, Hillon P

Soins. 2013 Nov;(780):28.

Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage.

Loffroy R, Estivalet L, Cherblanc V, Favelier S, Pottecher P, Hamza S, Minello A, Hillon P, Thouant P, Lefevre PH, Krause D, Cercueil JP

World J Gastroenterol. 2013 Oct 7;19(37):6131-43

[Health professionals' perceptions and screening for hepatitis B and C among migrants: a qualitative study in Cote-d'Or, France].

Enel C, Minello A, Hillon P

Sante Publique. 2012 Jul-Aug;24(4):303-15.

Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy.

Guiu B, Crevisy-Girod E, Binquet C, Duvillard L, Masson D, Lepage C, Hamza S, Krause D, Verges B, Minello A, Cercueil JP, Hillon P, Petit JM

Eur Radiol. 2012 Apr;22(4):855-63

Chronic viral hepatitis and risk of lymphoid malignancies: a retrospective twelve-year population-based cohort study in Cote d'Or, France.

Proby C, Minello A, Quantin C, Jooste V, Binquet C, Hagi M, Mounier M, Benzenine E, Hillon P, Maynadie M

Dig Liver Dis. 2012 Feb;44(2):160-5

Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma.

Boulin M, Ciboulet A, Guiu B, Maillard E, Bonnetain F, Minello A, Gagnaire A, Lepage C, Krause D, Hillon P, Bedenne L, Cercueil JP, Chauffert B, Jouve JL

Dig Liver Dis. 2011 Nov;43(11):905-11

Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis.

Di Martino V, Crouzet J, Hillon P, Thevenot T, Minello A, Monnet E

J Viral Hepat. 2011 Jul;18(7):493-505

Should Possible Recurrence of Disease Contraindicate Liver Transplantation in Patients With End-Stage Alveolar Echinococcosis? A 20-Year Follow-Up Study.

Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, Brientini MP, Richou C, Minello A, Antonino AT, Gillet M, Ito A, Mantion GA, Vuitton DA

Liver Transpl. 2011 Jul;17(7):855-65

Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol.

Thevenot T, Borot S, Remy-Martin A, Sapin R, Cervoni JP, Richou C, Vanlemmens C, Cleau D, Muel E, Minello A, Tirziu S, Penfornis A, Di Martino V, Monnet E

Liver Int. 2011 Mar;31(3):425-33

A 30-year, population-based study shows improved management and prognosis of hepatocellular carcinoma.

Guiu B, Minello A, Cottet V, Lepage C, Hillon P, Faivre J, Bouvier AM

Clin Gastroenterol Hepatol. 2010 Nov;8(11):986-91

Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.

Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, Deconinck E, Hillon P, Di Martino V

Liver Transpl. 2009 Jul;15(7):682-5.

Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.

Guiu B, Colin C, Cercueil JP, Loffroy R, Guiu S, Ferrant E, Jouve JL, Bonnetain F, Boulin M, Ghiringhelli F, Minello A, Hillon P, Bedenne L, Krause D, Chauffert B

Am J Clin Oncol. 2009 Jun;32(3):238-44.

[In chronic hepatitis C, delays between diagnosis and treatment are linked to the doctor-patient relationship]

Enel C, Minello A, Jooste V, Pinoit JM, Hillon P

Med Sci (Paris). 2009 May;25(5):519-23.

Immediate Listing for Liver Transplantation Versus Standard Care for Child-Pugh Stage B Alcoholic Cirrhosis A Randomized Trial

Vanlemmens C, Di Martino V, Milan C, Messner M, Minello A, Duvoux C, Poynard T, Perarnau JM, Piquet MAA, Pageaux GP, Dharancy S, Silvain C, Hillaire S, Thiefin G, Vinel JP, Hillon P, Collin E, Mantion G, Miguet JP

Ann Intern Med. 2009 Feb 3;150(3):153-61.